> top > docs > PMC:3342329 > spans > 20097-21381 > annotations

PMC:3342329 / 20097-21381 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T8934 1181-1185 Protein denotes CCR5
T8933 1121-1125 Protein denotes CCR5
T8932 838-845 Entity denotes nucleus
T8931 815-828 Localization denotes translocation
T8930 811-814 Protein denotes p65
T8929 803-806 Protein denotes p50
T8928 785-795 Negative_regulation denotes inhibition
T8927 740-755 Phosphorylation denotes phosphorylation
T8926 726-735 Negative_regulation denotes prevented
T8925 718-722 Protein denotes CCR5
T8924 695-703 Positive_regulation denotes enhanced
T8923 449-453 Protein denotes CCR5
T8862 1181-1185 Protein denotes CCR5
T8861 1121-1125 Protein denotes CCR5
T8860 811-814 Protein denotes p65
T8859 803-806 Protein denotes p50
T8858 718-722 Protein denotes CCR5
T8857 449-453 Protein denotes CCR5
R5898 T8927 T8926 themeOf phosphorylation,prevented
R5899 T8929 T8931 themeOf p50,translocation
R5900 T8930 T8931 themeOf p65,translocation
R5901 T8931 T8928 themeOf translocation,inhibition
R5902 T8932 T8931 locationOf nucleus,translocation

testone

Id Subject Object Predicate Lexical cue
T8826 838-845 Entity denotes nucleus
T8825 815-828 Localization denotes translocation
T8824 785-795 Negative_regulation denotes inhibition
T8823 740-755 Phosphorylation denotes phosphorylation
T8769 1181-1185 Protein denotes CCR5
T8768 1121-1125 Protein denotes CCR5
T8767 811-814 Protein denotes p65
T8766 803-806 Protein denotes p50
T8765 718-722 Protein denotes CCR5
T8764 449-453 Protein denotes CCR5
R5874 T8766 T8825 themeOf p50,translocation
R5875 T8767 T8825 themeOf p65,translocation
R5888 T8825 T8824 themeOf translocation,inhibition
R5889 T8826 T8825 locationOf nucleus,translocation

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T11124 1181-1185 Protein denotes CCR5
T11123 1121-1125 Protein denotes CCR5
T11122 811-814 Protein denotes p65
T11121 803-806 Protein denotes p50
T11120 718-722 Protein denotes CCR5
T11119 449-453 Protein denotes CCR5
T11177 815-828 Localization denotes translocation
T11176 785-795 Negative_regulation denotes inhibition
R7391 T11122 T11176 themeOf p65,inhibition
R7392 T11122 T11177 themeOf p65,translocation

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T10796 1181-1185 Protein denotes CCR5
T10795 1121-1125 Protein denotes CCR5
T10794 811-814 Protein denotes p65
T10793 803-806 Protein denotes p50
T10792 718-722 Protein denotes CCR5
T10791 449-453 Protein denotes CCR5
T10853 726-735 Negative_regulation denotes prevented
T10852 815-828 Localization denotes translocation
T10851 785-795 Negative_regulation denotes inhibition
R7309 T10792 T10853 themeOf CCR5,prevented
R7310 T10793 T10851 themeOf p50,inhibition
R7311 T10793 T10852 themeOf p50,translocation
R7312 T10794 T10851 themeOf p65,inhibition
R7313 T10794 T10852 themeOf p65,translocation

2_test

Id Subject Object Predicate Lexical cue
22567084-10602461-91707037 118-120 10602461 denotes 39
22567084-19823771-91707038 926-928 19823771 denotes 40

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T9809 1274-1283 NN denotes cytokines
T9808 1269-1273 JJ denotes many
T9807 1266-1268 IN denotes by
T9806 1254-1265 VB denotes inactivated
T9805 1251-1253 CC denotes or
T9804 1241-1250 VB denotes activated
T9803 1238-1240 VB denotes is
T9802 1232-1237 NN denotes NF-κB
T9801 1227-1231 IN denotes that
T9800 1216-1226 JJ denotes noteworthy
T9799 1213-1215 VB denotes is
T9798 1210-1212 PRP denotes it
T9797 1208-1209 -COMMA- denotes ,
T9796 1203-1208 NN denotes NF-κB
T9795 1189-1202 VB denotes downregulates
T9794 1181-1188 NN denotes CCR5−/−
T9793 1177-1180 WRB denotes how
T9792 1174-1176 TO denotes to
T9791 1171-1173 IN denotes as
T9790 1165-1170 JJ denotes clear
T9789 1161-1164 RB denotes not
T9788 1158-1160 VB denotes is
T9787 1148-1157 NN denotes mechanism
T9786 1144-1147 DT denotes the
T9785 1135-1143 IN denotes Although
T9784 1129-1133 NN denotes mice
T9783 1121-1128 NN denotes CCR5−/−
T9782 1118-1120 IN denotes in
T9781 1111-1117 NN denotes growth
T9780 1105-1110 NN denotes tumor
T9779 1102-1104 IN denotes of
T9778 1091-1101 NN denotes inhibition
T9777 1087-1090 DT denotes the
T9776 1084-1086 IN denotes in
T9775 1075-1083 JJ denotes critical
T9774 1071-1074 VB denotes are
T9773 1065-1070 NN denotes genes
T9772 1058-1064 NN denotes target
T9771 1055-1057 IN denotes of
T9770 1044-1054 NN denotes expression
T9769 1040-1043 DT denotes the
T9768 1036-1039 CC denotes and
T9767 1027-1035 NN denotes activity
T9766 1021-1026 NN denotes NF-κB
T9765 1018-1020 IN denotes of
T9764 1006-1017 NN denotes inhibitions
T9763 1002-1005 DT denotes the
T9762 1000-1001 -COMMA- denotes ,
T9761 996-1000 RB denotes Thus
T9760 988-994 NN denotes growth
T9759 979-987 NN denotes melanoma
T9758 975-978 IN denotes for
T9757 968-974 NN denotes factor
T9756 959-967 NN denotes survival
T9755 957-958 DT denotes a
T9754 954-956 IN denotes as
T9753 947-953 VB denotes acting
T9752 940-946 RB denotes likely
T9751 937-939 VB denotes is
T9750 931-936 WDT denotes which
T9749 929-930 -COMMA- denotes ,
T9748 928-929 -RRB- denotes ]
T9747 926-928 CD denotes 40
T9746 925-926 -LRB- denotes [
T9745 919-924 NN denotes NF-κB
T9744 916-918 IN denotes of
T9743 909-915 NN denotes levels
T9742 899-908 VB denotes increased
T9741 894-898 VB denotes have
T9740 892-893 -COMMA- denotes ,
T9739 884-892 NN denotes melanoma
T9738 874-883 VB denotes including
T9737 872-873 -COMMA- denotes ,
T9736 866-872 NN denotes tumors
T9735 861-865 JJ denotes Many
T9734 858-859 -RRB- denotes )
T9733 854-858 NN denotes 2A-C
T9732 847-853 NN denotes Figure
T9731 846-847 -LRB- denotes (
T9730 838-845 NN denotes nucleus
T9729 834-837 DT denotes the
T9728 829-833 IN denotes into
T9727 815-828 NN denotes translocation
T9726 811-814 NN denotes p65
T9725 807-810 CC denotes and
T9724 803-806 NN denotes p50
T9723 799-802 DT denotes the
T9722 796-798 IN denotes of
T9721 785-795 NN denotes inhibition
T9720 781-784 DT denotes the
T9719 776-780 IN denotes with
T9718 764-775 VB denotes accompanied
T9717 762-763 -COMMA- denotes ,
T9716 759-762 NN denotes IκB
T9715 756-758 IN denotes of
T9714 740-755 NN denotes phosphorylation
T9713 736-739 DT denotes the
T9712 726-735 VB denotes prevented
T9711 718-725 NN denotes CCR5−/−
T9710 716-717 -COMMA- denotes ,
T9709 708-716 NN denotes addition
T9708 705-707 IN denotes In
T9707 695-703 VB denotes enhanced
T9706 690-694 VB denotes were
T9705 685-689 NN denotes cIAP
T9704 681-684 CC denotes and
T9703 675-680 NN denotes Bcl-2
T9702 672-674 IN denotes as
T9701 667-671 JJ denotes such
T9700 665-666 -COMMA- denotes ,
T9699 660-665 NN denotes genes
T9698 653-659 NN denotes target
T9697 647-652 NN denotes NF-κB
T9696 636-646 JJ denotes inhibitory
T9695 630-635 NN denotes death
T9694 625-629 NN denotes cell
T9693 622-624 IN denotes of
T9692 611-621 NN denotes expression
T9691 607-610 DT denotes the
T9690 603-606 CC denotes but
T9689 601-602 -COMMA- denotes ,
T9688 592-601 VB denotes inhibited
T9687 578-591 RB denotes significantly
T9686 573-577 VB denotes were
T9685 571-572 -COMMA- denotes ,
T9684 566-571 NN denotes NF-κB
T9683 563-565 IN denotes of
T9682 554-562 NN denotes activity
T9681 546-553 NN denotes binding
T9680 542-545 NN denotes DNA
T9679 538-541 DT denotes the
T9678 534-537 CC denotes and
T9677 532-533 -RRB- denotes )
T9676 531-532 CD denotes 9
T9675 527-530 CC denotes and
T9674 517-526 NN denotes caspase-3
T9673 515-516 -COMMA- denotes ,
T9672 512-515 NN denotes Bax
T9671 511-512 -LRB- denotes (
T9670 505-510 NN denotes genes
T9669 499-504 NN denotes death
T9668 494-498 NN denotes cell
T9667 487-493 NN denotes target
T9666 481-486 NN denotes NF-κB
T9665 478-480 IN denotes of
T9664 467-477 NN denotes expression
T9663 463-466 DT denotes the
T9662 461-462 -COMMA- denotes ,
T9661 457-461 NN denotes mice
T9660 449-456 NN denotes CCR5−/−
T9659 445-448 DT denotes the
T9658 442-444 IN denotes of
T9657 434-441 NN denotes tissues
T9656 428-433 NN denotes tumor
T9655 419-427 NN denotes melanoma
T9654 415-418 DT denotes the
T9653 412-414 IN denotes In
T9652 402-410 NN denotes immunity
T9651 391-401 JJ denotes anti-tumor
T9650 388-390 CC denotes or
T9649 376-387 NN denotes development
T9648 369-375 NN denotes cancer
T9647 349-368 JJ denotes cytokine-associated
T9646 345-348 IN denotes for
T9645 333-344 JJ denotes responsible
T9644 326-332 NN denotes factor
T9643 320-325 JJ denotes major
T9642 318-319 DT denotes a
T9641 315-317 IN denotes as
T9640 304-314 VB denotes recognized
T9593 34-38 IN denotes over
T9592 31-33 IN denotes of
T9591 20-30 NN denotes expression
T9590 16-19 DT denotes the
T9589 6-15 VB denotes regulates
T9588 0-5 NN denotes NF-κB
T9639 299-303 VB denotes been
T9638 295-298 VB denotes has
T9637 289-294 NN denotes NF-κB
T9636 287-288 -COMMA- denotes ,
T9635 278-287 NN denotes responses
T9634 271-277 JJ denotes immune
T9633 263-270 JJ denotes diverse
T9632 260-262 IN denotes in
T9631 252-259 NN denotes factors
T9630 238-251 NN denotes transcription
T9629 233-237 NN denotes core
T9628 230-232 IN denotes as
T9627 224-229 NN denotes roles
T9626 220-223 PRP-DOLLAR- denotes its
T9625 216-219 CC denotes and
T9624 206-215 NN denotes mediators
T9623 193-205 JJ denotes inflammatory
T9622 190-192 IN denotes of
T9621 184-189 NN denotes array
T9620 178-183 JJ denotes large
T9619 176-177 DT denotes a
T9618 173-175 IN denotes of
T9617 162-172 NN denotes expression
T9616 158-161 DT denotes the
T9615 151-157 VB denotes induce
T9614 148-150 TO denotes to
T9613 138-147 NN denotes abilities
T9612 134-137 PRP-DOLLAR- denotes its
T9611 131-133 IN denotes of
T9610 123-130 IN denotes Because
T9609 120-121 -RRB- denotes ]
T9608 118-120 CD denotes 39
T9607 117-118 -LRB- denotes [
T9606 104-116 NN denotes inflammation
T9605 100-103 CC denotes and
T9604 93-99 NN denotes growth
T9603 88-92 NN denotes cell
T9602 81-87 NN denotes cancer
T9601 79-80 -COMMA- denotes ,
T9600 73-79 NN denotes system
T9599 66-72 JJ denotes immune
T9598 62-65 DT denotes the
T9597 54-61 VB denotes control
T9596 49-53 WDT denotes that
T9595 43-48 NN denotes genes
T9594 39-42 CD denotes 200
R6138 T9588 T9589 arg1Of NF-κB,regulates
R6139 T9589 T9607 arg1Of regulates,[
R6140 T9591 T9589 arg2Of expression,regulates
R6141 T9591 T9590 arg1Of expression,the
R6142 T9591 T9592 arg1Of expression,of
R6143 T9594 T9593 arg1Of 200,over
R6144 T9595 T9592 arg2Of genes,of
R6145 T9595 T9594 arg1Of genes,200
R6146 T9595 T9596 arg1Of genes,that
R6147 T9595 T9597 arg1Of genes,control
R6148 T9600 T9599 arg1Of system,immune
R6149 T9600 T9601 arg1Of system,","
R6150 T9601 T9605 arg1Of ",",and
R6151 T9604 T9601 arg2Of growth,","
R6152 T9604 T9602 arg1Of growth,cancer
R6153 T9604 T9603 arg1Of growth,cell
R6154 T9605 T9597 arg2Of and,control
R6155 T9605 T9598 arg1Of and,the
R6156 T9606 T9605 arg2Of inflammation,and
R6157 T9608 T9607 arg2Of 39,[
R6158 T9609 T9607 arg3Of ],[
R6159 T9610 T9611 arg1Of Because,of
R6160 T9613 T9610 arg2Of abilities,Because
R6161 T9613 T9612 arg1Of abilities,its
R6162 T9613 T9614 modOf abilities,to
R6163 T9615 T9614 arg1Of induce,to
R6164 T9617 T9615 arg2Of expression,induce
R6165 T9617 T9616 arg1Of expression,the
R6166 T9617 T9618 arg1Of expression,of
R6167 T9617 T9628 arg1Of expression,as
R6168 T9617 T9632 arg1Of expression,in
R6169 T9621 T9618 arg2Of array,of
R6170 T9621 T9619 arg1Of array,a
R6171 T9621 T9620 arg1Of array,large
R6172 T9621 T9622 arg1Of array,of
R6173 T9624 T9623 arg1Of mediators,inflammatory
R6174 T9624 T9625 arg1Of mediators,and
R6175 T9625 T9622 arg2Of and,of
R6176 T9627 T9625 arg2Of roles,and
R6177 T9627 T9626 arg1Of roles,its
R6178 T9631 T9628 arg2Of factors,as
R6179 T9631 T9629 arg1Of factors,core
R6180 T9631 T9630 arg1Of factors,transcription
R6181 T9635 T9632 arg2Of responses,in
R6182 T9635 T9633 arg1Of responses,diverse
R6183 T9635 T9634 arg1Of responses,immune
R6184 T9637 T9638 arg1Of NF-κB,has
R6185 T9637 T9639 arg1Of NF-κB,been
R6186 T9637 T9640 arg2Of NF-κB,recognized
R6187 T9640 T9610 arg1Of recognized,Because
R6188 T9640 T9636 arg1Of recognized,","
R6189 T9640 T9638 arg2Of recognized,has
R6190 T9640 T9639 arg2Of recognized,been
R6191 T9640 T9641 arg1Of recognized,as
R6192 T9644 T9641 arg2Of factor,as
R6193 T9644 T9642 arg1Of factor,a
R6194 T9644 T9643 arg1Of factor,major
R6195 T9644 T9645 arg1Of factor,responsible
R6196 T9645 T9646 arg1Of responsible,for
R6197 T9649 T9647 arg1Of development,cytokine-associated
R6198 T9649 T9648 arg1Of development,cancer
R6199 T9649 T9650 arg1Of development,or
R6200 T9650 T9646 arg2Of or,for
R6201 T9652 T9650 arg2Of immunity,or
R6202 T9652 T9651 arg1Of immunity,anti-tumor
R6203 T9657 T9653 arg2Of tissues,In
R6204 T9657 T9654 arg1Of tissues,the
R6205 T9657 T9655 arg1Of tissues,melanoma
R6206 T9657 T9656 arg1Of tissues,tumor
R6207 T9657 T9658 arg1Of tissues,of
R6208 T9661 T9658 arg2Of mice,of
R6209 T9661 T9659 arg1Of mice,the
R6210 T9661 T9660 arg1Of mice,CCR5−/−
R6211 T9664 T9663 arg1Of expression,the
R6212 T9664 T9665 arg1Of expression,of
R6213 T9664 T9686 arg1Of expression,were
R6214 T9664 T9688 arg2Of expression,inhibited
R6215 T9670 T9666 arg1Of genes,NF-κB
R6216 T9670 T9667 arg1Of genes,target
R6217 T9670 T9668 arg1Of genes,cell
R6218 T9670 T9669 arg1Of genes,death
R6219 T9670 T9671 arg1Of genes,(
R6220 T9670 T9678 arg1Of genes,and
R6221 T9672 T9673 arg1Of Bax,","
R6222 T9673 T9675 arg1Of ",",and
R6223 T9674 T9673 arg2Of caspase-3,","
R6224 T9675 T9671 arg2Of and,(
R6225 T9676 T9675 arg2Of 9,and
R6226 T9677 T9671 arg3Of ),(
R6227 T9678 T9665 arg2Of and,of
R6228 T9682 T9678 arg2Of activity,and
R6229 T9682 T9679 arg1Of activity,the
R6230 T9682 T9680 arg1Of activity,DNA
R6231 T9682 T9681 arg1Of activity,binding
R6232 T9682 T9683 arg1Of activity,of
R6233 T9684 T9683 arg2Of NF-κB,of
R6234 T9688 T9653 arg1Of inhibited,In
R6235 T9688 T9662 arg1Of inhibited,","
R6236 T9688 T9685 arg1Of inhibited,","
R6237 T9688 T9686 arg2Of inhibited,were
R6238 T9688 T9687 arg1Of inhibited,significantly
R6239 T9688 T9690 arg1Of inhibited,but
R6240 T9690 T9689 arg1Of but,","
R6241 T9692 T9691 arg1Of expression,the
R6242 T9692 T9693 arg1Of expression,of
R6243 T9692 T9706 arg1Of expression,were
R6244 T9692 T9707 arg2Of expression,enhanced
R6245 T9699 T9693 arg2Of genes,of
R6246 T9699 T9694 arg1Of genes,cell
R6247 T9699 T9695 arg1Of genes,death
R6248 T9699 T9696 arg1Of genes,inhibitory
R6249 T9699 T9697 arg1Of genes,NF-κB
R6250 T9699 T9698 arg1Of genes,target
R6251 T9699 T9700 arg1Of genes,","
R6252 T9699 T9702 arg1Of genes,as
R6253 T9702 T9701 arg1Of as,such
R6254 T9703 T9704 arg1Of Bcl-2,and
R6255 T9704 T9702 arg2Of and,as
R6256 T9705 T9704 arg2Of cIAP,and
R6257 T9707 T9690 arg2Of enhanced,but
R6258 T9707 T9706 arg2Of enhanced,were
R6259 T9709 T9708 arg2Of addition,In
R6260 T9711 T9712 arg1Of CCR5−/−,prevented
R6261 T9712 T9708 arg1Of prevented,In
R6262 T9712 T9710 arg1Of prevented,","
R6263 T9714 T9712 arg2Of phosphorylation,prevented
R6264 T9714 T9713 arg1Of phosphorylation,the
R6265 T9714 T9715 arg1Of phosphorylation,of
R6266 T9714 T9717 arg1Of phosphorylation,","
R6267 T9714 T9718 arg2Of phosphorylation,accompanied
R6268 T9714 T9731 arg1Of phosphorylation,(
R6269 T9716 T9715 arg2Of IκB,of
R6270 T9718 T9719 arg1Of accompanied,with
R6271 T9721 T9719 arg2Of inhibition,with
R6272 T9721 T9720 arg1Of inhibition,the
R6273 T9721 T9722 arg1Of inhibition,of
R6274 T9721 T9728 arg1Of inhibition,into
R6275 T9724 T9725 arg1Of p50,and
R6276 T9726 T9725 arg2Of p65,and
R6277 T9727 T9722 arg2Of translocation,of
R6278 T9727 T9723 arg1Of translocation,the
R6279 T9727 T9724 arg1Of translocation,p50
R6280 T9727 T9726 arg1Of translocation,p65
R6281 T9730 T9728 arg2Of nucleus,into
R6282 T9730 T9729 arg1Of nucleus,the
R6283 T9733 T9731 arg2Of 2A-C,(
R6284 T9733 T9732 arg1Of 2A-C,Figure
R6285 T9734 T9731 arg3Of ),(
R6286 T9736 T9735 arg1Of tumors,Many
R6287 T9736 T9737 arg1Of tumors,","
R6288 T9736 T9738 arg1Of tumors,including
R6289 T9736 T9741 arg1Of tumors,have
R6290 T9736 T9742 arg1Of tumors,increased
R6291 T9739 T9738 arg2Of melanoma,including
R6292 T9742 T9740 arg1Of increased,","
R6293 T9742 T9741 arg2Of increased,have
R6294 T9743 T9742 arg2Of levels,increased
R6295 T9743 T9744 arg1Of levels,of
R6296 T9745 T9744 arg2Of NF-κB,of
R6297 T9745 T9746 arg1Of NF-κB,[
R6298 T9745 T9749 arg1Of NF-κB,","
R6299 T9745 T9750 arg1Of NF-κB,which
R6300 T9745 T9751 arg1Of NF-κB,is
R6301 T9745 T9753 arg1Of NF-κB,acting
R6302 T9747 T9746 arg2Of 40,[
R6303 T9748 T9746 arg3Of ],[
R6304 T9753 T9751 arg2Of acting,is
R6305 T9753 T9752 arg1Of acting,likely
R6306 T9753 T9754 arg1Of acting,as
R6307 T9757 T9754 arg2Of factor,as
R6308 T9757 T9755 arg1Of factor,a
R6309 T9757 T9756 arg1Of factor,survival
R6310 T9757 T9758 arg1Of factor,for
R6311 T9760 T9758 arg2Of growth,for
R6312 T9760 T9759 arg1Of growth,melanoma
R6313 T9764 T9763 arg1Of inhibitions,the
R6314 T9764 T9765 arg1Of inhibitions,of
R6315 T9764 T9768 arg1Of inhibitions,and
R6316 T9767 T9765 arg2Of activity,of
R6317 T9767 T9766 arg1Of activity,NF-κB
R6318 T9768 T9774 arg1Of and,are
R6319 T9768 T9775 arg1Of and,critical
R6320 T9770 T9768 arg2Of expression,and
R6321 T9770 T9769 arg1Of expression,the
R6322 T9770 T9771 arg1Of expression,of
R6323 T9773 T9771 arg2Of genes,of
R6324 T9773 T9772 arg1Of genes,target
R6325 T9774 T9761 arg1Of are,Thus
R6326 T9774 T9762 arg1Of are,","
R6327 T9775 T9774 arg2Of critical,are
R6328 T9775 T9776 arg1Of critical,in
R6329 T9778 T9776 arg2Of inhibition,in
R6330 T9778 T9777 arg1Of inhibition,the
R6331 T9778 T9779 arg1Of inhibition,of
R6332 T9781 T9779 arg2Of growth,of
R6333 T9781 T9780 arg1Of growth,tumor
R6334 T9781 T9782 arg1Of growth,in
R6335 T9784 T9782 arg2Of mice,in
R6336 T9784 T9783 arg1Of mice,CCR5−/−
R6337 T9787 T9786 arg1Of mechanism,the
R6338 T9787 T9788 arg1Of mechanism,is
R6339 T9787 T9790 arg1Of mechanism,clear
R6340 T9788 T9785 arg2Of is,Although
R6341 T9788 T9789 arg1Of is,not
R6342 T9790 T9788 arg2Of clear,is
R6343 T9790 T9792 arg1Of clear,to
R6344 T9792 T9791 arg1Of to,as
R6345 T9793 T9792 arg2Of how,to
R6346 T9794 T9795 arg1Of CCR5−/−,downregulates
R6347 T9795 T9793 arg1Of downregulates,how
R6348 T9796 T9795 arg2Of NF-κB,downregulates
R6349 T9799 T9785 arg1Of is,Although
R6350 T9799 T9797 arg1Of is,","
R6351 T9800 T9799 arg2Of noteworthy,is
R6352 T9802 T9803 arg1Of NF-κB,is
R6353 T9802 T9804 arg2Of NF-κB,activated
R6354 T9802 T9806 arg2Of NF-κB,inactivated
R6355 T9804 T9805 arg1Of activated,or
R6356 T9805 T9798 arg1Of or,it
R6357 T9805 T9799 arg1Of or,is
R6358 T9805 T9800 arg1Of or,noteworthy
R6359 T9805 T9801 arg1Of or,that
R6360 T9805 T9803 arg2Of or,is
R6361 T9806 T9805 arg2Of inactivated,or
R6362 T9809 T9804 arg1Of cytokines,activated
R6363 T9809 T9806 arg1Of cytokines,inactivated
R6364 T9809 T9807 arg2Of cytokines,by
R6365 T9809 T9808 arg1Of cytokines,many

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T9171 1181-1185 Protein denotes CCR5
T9170 1121-1125 Protein denotes CCR5
T9169 811-814 Protein denotes p65
T9168 803-806 Protein denotes p50
T9167 718-722 Protein denotes CCR5
T9166 449-453 Protein denotes CCR5

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T10929 811-814 http://www.uniprot.org/uniprot/P21579 denotes p65
T10928 811-814 http://www.uniprot.org/uniprot/Q04206 denotes p65
T10927 803-806 http://www.uniprot.org/uniprot/P19838 denotes p50
T10921 517-526 http://www.uniprot.org/uniprot/P42574 denotes caspase-3
T10879 1181-1185 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10878 1121-1125 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10877 718-722 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10876 449-453 http://www.uniprot.org/uniprot/P51681 denotes CCR5

UBERON-AE

Id Subject Object Predicate Lexical cue
T9008 66-79 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system

GO-BP

Id Subject Object Predicate Lexical cue
T9258 740-762 http://purl.obolibrary.org/obo/GO_0007252 denotes phosphorylation of IκB
T9257 740-755 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T9255 630-635 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T9254 499-504 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T9252 625-635 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T9251 494-504 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T9250 376-387 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T9246 271-287 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T9245 238-251 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T9244 104-116 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T9242 88-99 http://purl.obolibrary.org/obo/GO_0016049 denotes cell growth
T9224 1111-1117 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9223 988-994 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9222 93-99 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-MF

Id Subject Object Predicate Lexical cue
T9316 546-553 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T9315 542-553 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA binding

GO-CC

Id Subject Object Predicate Lexical cue
T9311 838-845 http://purl.obolibrary.org/obo/GO_0005634 denotes nucleus
T9310 233-237 http://purl.obolibrary.org/obo/GO_0019013 denotes core

sentences

Id Subject Object Predicate Lexical cue
T9021 1135-1284 Sentence denotes Although the mechanism is not clear as to how CCR5−/− downregulates NF-κB, it is noteworthy that NF-κB is activated or inactivated by many cytokines.
T9020 996-1134 Sentence denotes Thus, the inhibitions of NF-κB activity and the expression of target genes are critical in the inhibition of tumor growth in CCR5−/− mice.
T9019 861-995 Sentence denotes Many tumors, including melanoma, have increased levels of NF-κB [40], which is likely acting as a survival factor for melanoma growth.
T9018 705-860 Sentence denotes In addition, CCR5−/− prevented the phosphorylation of IκB, accompanied with the inhibition of the p50 and p65 translocation into the nucleus (Figure 2A-C).
T9017 412-704 Sentence denotes In the melanoma tumor tissues of the CCR5−/− mice, the expression of NF-κB target cell death genes (Bax, caspase-3 and 9) and the DNA binding activity of NF-κB, were significantly inhibited, but the expression of cell death inhibitory NF-κB target genes, such as Bcl-2 and cIAP were enhanced.
T9016 123-411 Sentence denotes Because of its abilities to induce the expression of a large array of inflammatory mediators and its roles as core transcription factors in diverse immune responses, NF-κB has been recognized as a major factor responsible for cytokine-associated cancer development or anti-tumor immunity.
T9015 0-122 Sentence denotes NF-κB regulates the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39].
T157 0-122 Sentence denotes NF-κB regulates the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39].
T158 123-411 Sentence denotes Because of its abilities to induce the expression of a large array of inflammatory mediators and its roles as core transcription factors in diverse immune responses, NF-κB has been recognized as a major factor responsible for cytokine-associated cancer development or anti-tumor immunity.
T159 412-704 Sentence denotes In the melanoma tumor tissues of the CCR5−/− mice, the expression of NF-κB target cell death genes (Bax, caspase-3 and 9) and the DNA binding activity of NF-κB, were significantly inhibited, but the expression of cell death inhibitory NF-κB target genes, such as Bcl-2 and cIAP were enhanced.
T160 705-860 Sentence denotes In addition, CCR5−/− prevented the phosphorylation of IκB, accompanied with the inhibition of the p50 and p65 translocation into the nucleus (Figure 2A-C).
T161 861-995 Sentence denotes Many tumors, including melanoma, have increased levels of NF-κB [40], which is likely acting as a survival factor for melanoma growth.
T162 996-1134 Sentence denotes Thus, the inhibitions of NF-κB activity and the expression of target genes are critical in the inhibition of tumor growth in CCR5−/− mice.
T163 1135-1284 Sentence denotes Although the mechanism is not clear as to how CCR5−/− downregulates NF-κB, it is noteworthy that NF-κB is activated or inactivated by many cytokines.

simple1

Id Subject Object Predicate Lexical cue
T9364 1181-1185 Protein denotes CCR5
T9363 1121-1125 Protein denotes CCR5
T9362 811-814 Protein denotes p65
T9361 803-806 Protein denotes p50
T9360 718-722 Protein denotes CCR5
T9359 449-453 Protein denotes CCR5

DLUT931

Id Subject Object Predicate Lexical cue
T11011 1189-1202 Negative_regulation denotes downregulates
T11010 815-828 Localization denotes translocation
T11009 785-795 Negative_regulation denotes inhibition
T10953 1181-1185 Protein denotes CCR5
T10952 1121-1125 Protein denotes CCR5
T10951 811-814 Protein denotes p65
T10950 803-806 Protein denotes p50
T10949 718-722 Protein denotes CCR5
T10948 449-453 Protein denotes CCR5
R7327 T11010 T11009 themeOf translocation,inhibition
R7339 T10950 T11009 themeOf p50,inhibition
R7340 T10950 T11010 themeOf p50,translocation
R7341 T10951 T11009 themeOf p65,inhibition
R7342 T10951 T11010 themeOf p65,translocation
R7343 T10953 T11011 themeOf CCR5,downregulates
R7345 T11010 T11009 themeOf translocation,inhibition

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T11675 1040-1070 Gene_expression denotes the expression of target genes
T11672 1227-1283 Positive_regulation denotes that NF-κB is activated or inactivated by many cytokines
T11671 16-121 Gene_expression denotes the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39]
T11669 0-121 Regulation denotes NF-κB regulates the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39]
T11667 1129-1133 Protein denotes mice
T11649 505-533 Protein denotes genes (Bax, caspase-3 and 9)
T11638 1266-1283 Protein denotes by many cytokines
T11635 1055-1070 Protein denotes of target genes
T11632 563-571 Protein denotes of NF-κB
T11631 0-5 Protein denotes NF-κB
T11628 517-526 Protein denotes caspase-3
T11625 512-515 Protein denotes Bax
T11617 349-368 Protein denotes cytokine-associated
T11613 675-680 Protein denotes Bcl-2
T11607 233-237 Entity denotes core
T11606 919-930 Protein denotes NF-κB [40],
T11604 799-806 Protein denotes the p50
T11603 1232-1237 Protein denotes NF-κB
T11600 31-121 Protein denotes of over 200 genes that control the immune system, cancer cell growth and inflammation [39]
T11577 834-845 Entity denotes the nucleus
T11562 1021-1026 Protein denotes NF-κB
T11560 415-462 Protein denotes the melanoma tumor tissues of the CCR5−/− mice,
T11557 653-674 Protein denotes target genes, such as
T11554 622-689 Protein denotes of cell death inhibitory NF-κB target genes, such as Bcl-2 and cIAP
T11550 478-486 Protein denotes of NF-κB
T11547 463-577 Entity denotes the expression of NF-κB target cell death genes (Bax, caspase-3 and 9) and the DNA binding activity of NF-κB, were
T11545 811-814 Protein denotes p65
T11542 1203-1208 Protein denotes NF-κB
T11525 289-294 Protein denotes NF-κB
T11516 647-652 Protein denotes NF-κB
T11694 1227-1283 Negative_regulation denotes that NF-κB is activated or inactivated by many cytokines
T11693 607-689 Gene_expression denotes the expression of cell death inhibitory NF-κB target genes, such as Bcl-2 and cIAP
T11688 463-486 Gene_expression denotes the expression of NF-κB
T11686 415-462 Localization denotes the melanoma tumor tissues of the CCR5−/− mice,
R7561 T11550 T11688 themeOf of NF-κB,the expression of NF-κB
R7564 T11554 T11693 themeOf "of cell death inhibitory NF-κB target genes, such as Bcl-2 and cIAP","the expression of cell death inhibitory NF-κB target genes, such as Bcl-2 and cIAP"
R7565 T11631 T11669 causeOf NF-κB,"NF-κB regulates the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39]"
R7566 T11635 T11675 themeOf of target genes,the expression of target genes
R7567 T11560 T11686 themeOf "the melanoma tumor tissues of the CCR5−/− mice,","the melanoma tumor tissues of the CCR5−/− mice,"
R7569 T11638 T11694 causeOf by many cytokines,that NF-κB is activated or inactivated by many cytokines
R7577 T11671 T11669 themeOf "the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39]","NF-κB regulates the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39]"
R7581 T11600 T11671 themeOf "of over 200 genes that control the immune system, cancer cell growth and inflammation [39]","the expression of over 200 genes that control the immune system, cancer cell growth and inflammation [39]"
R7584 T11603 T11672 themeOf NF-κB,that NF-κB is activated or inactivated by many cytokines
R7585 T11603 T11694 themeOf NF-κB,that NF-κB is activated or inactivated by many cytokines

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T12134 1283-1284 . denotes .
T12133 1274-1283 NNS denotes cytokines
T12132 1269-1273 JJ denotes many
T12131 1266-1268 IN denotes by
T12130 1254-1265 VBN denotes inactivated
T12129 1251-1253 CC denotes or
T12128 1241-1250 VBN denotes activated
T12127 1238-1240 VBZ denotes is
T12126 1232-1237 NNP denotes NF-κB
T12125 1227-1231 IN denotes that
T12124 1216-1226 JJ denotes noteworthy
T12123 1213-1215 VBZ denotes is
T12122 1210-1212 PRP denotes it
T12121 1208-1209 , denotes ,
T12120 1203-1208 NNP denotes NF-κB
T12119 1189-1202 VBZ denotes downregulates
T12118 1187-1188 NN denotes −
T12117 1186-1187 CD denotes /
T12116 1185-1186 VBD denotes −
T12115 1181-1185 NNP denotes CCR5
T12114 1177-1180 WRB denotes how
T12113 1174-1176 TO denotes to
T12112 1171-1173 IN denotes as
T12111 1165-1170 JJ denotes clear
T12110 1161-1164 RB denotes not
T12109 1158-1160 VBZ denotes is
T12108 1148-1157 NN denotes mechanism
T12107 1144-1147 DT denotes the
T12106 1135-1143 IN denotes Although
T12105 1133-1134 . denotes .
T12104 1129-1133 NNS denotes mice
T12103 1127-1128 NN denotes −
T12102 1126-1127 NN denotes /
T12101 1125-1126 CD denotes −
T12100 1121-1125 CD denotes CCR5
T12099 1118-1120 IN denotes in
T12098 1111-1117 NN denotes growth
T12097 1105-1110 NN denotes tumor
T12096 1102-1104 IN denotes of
T12095 1091-1101 NN denotes inhibition
T11957 388-390 CC denotes or
T11956 376-387 NN denotes development
T11955 369-375 NN denotes cancer
T11954 349-368 JJ denotes cytokine-associated
T11953 345-348 IN denotes for
T11952 333-344 JJ denotes responsible
T11951 326-332 NN denotes factor
T11950 320-325 JJ denotes major
T11949 318-319 DT denotes a
T11948 315-317 IN denotes as
T11947 304-314 VBN denotes recognized
T11946 299-303 VBN denotes been
T11945 295-298 VBZ denotes has
T11944 289-294 NNP denotes NF-κB
T11943 287-288 , denotes ,
T11942 278-287 NNS denotes responses
T11941 271-277 JJ denotes immune
T11940 263-270 JJ denotes diverse
T11939 260-262 IN denotes in
T11938 252-259 NNS denotes factors
T11937 238-251 NN denotes transcription
T11936 233-237 NN denotes core
T11935 230-232 IN denotes as
T11934 224-229 NNS denotes roles
T11933 220-223 PRP$ denotes its
T11932 216-219 CC denotes and
T11931 206-215 NNS denotes mediators
T11930 193-205 JJ denotes inflammatory
T11929 190-192 IN denotes of
T11928 184-189 NN denotes array
T11927 178-183 JJ denotes large
T11926 176-177 DT denotes a
T11925 173-175 IN denotes of
T11924 162-172 NN denotes expression
T11923 158-161 DT denotes the
T11922 151-157 VB denotes induce
T11921 148-150 TO denotes to
T11920 138-147 NNS denotes abilities
T11919 134-137 PRP$ denotes its
T11918 131-133 IN denotes of
T11917 123-130 IN denotes Because
T11916 121-122 . denotes .
T11915 120-121 NNP denotes ]
T11914 118-120 CD denotes 39
T11913 117-118 NNP denotes [
T11912 104-116 NN denotes inflammation
T11911 100-103 CC denotes and
T11910 93-99 NN denotes growth
T11909 88-92 NN denotes cell
T11908 81-87 NN denotes cancer
T11907 79-80 , denotes ,
T11906 73-79 NN denotes system
T11905 66-72 JJ denotes immune
T11904 62-65 DT denotes the
T11903 54-61 VBP denotes control
T11902 49-53 WDT denotes that
T11901 43-48 NNS denotes genes
T11900 39-42 CD denotes 200
T11899 34-38 IN denotes over
T11898 31-33 IN denotes of
T11897 20-30 NN denotes expression
T11896 16-19 DT denotes the
T11895 6-15 VBZ denotes regulates
T11894 0-5 JJ denotes NF-κB
T12094 1087-1090 DT denotes the
T12093 1084-1086 IN denotes in
T12092 1075-1083 JJ denotes critical
T12091 1071-1074 VBP denotes are
T12090 1065-1070 NNS denotes genes
T12089 1058-1064 NN denotes target
T12088 1055-1057 IN denotes of
T12087 1044-1054 NN denotes expression
T12086 1040-1043 DT denotes the
T12085 1036-1039 CC denotes and
T12084 1027-1035 NN denotes activity
T12083 1021-1026 JJ denotes NF-κB
T12082 1018-1020 IN denotes of
T12081 1006-1017 NNS denotes inhibitions
T12080 1002-1005 DT denotes the
T12079 1000-1001 , denotes ,
T12078 996-1000 RB denotes Thus
T12077 994-995 . denotes .
T12076 988-994 NN denotes growth
T12075 979-987 NN denotes melanoma
T12074 975-978 IN denotes for
T12073 968-974 NN denotes factor
T12072 959-967 NN denotes survival
T12071 957-958 DT denotes a
T12070 954-956 IN denotes as
T12069 947-953 VBG denotes acting
T12068 940-946 JJ denotes likely
T12067 937-939 VBZ denotes is
T12066 931-936 WDT denotes which
T12065 929-930 , denotes ,
T12064 928-929 NNP denotes ]
T12063 926-928 CD denotes 40
T12062 925-926 NNP denotes [
T12061 919-924 NNP denotes NF-κB
T12060 916-918 IN denotes of
T12059 909-915 NNS denotes levels
T12058 899-908 VBN denotes increased
T12057 894-898 VBP denotes have
T12056 892-893 , denotes ,
T12055 884-892 NN denotes melanoma
T12054 874-883 VBG denotes including
T12053 872-873 , denotes ,
T12052 866-872 NNS denotes tumors
T12051 861-865 JJ denotes Many
T12050 859-860 . denotes .
T12049 858-859 -RRB- denotes )
T12048 854-858 NN denotes 2A-C
T12047 847-853 NN denotes Figure
T12046 846-847 -LRB- denotes (
T12045 838-845 NN denotes nucleus
T12044 834-837 DT denotes the
T12043 829-833 IN denotes into
T12042 815-828 NN denotes translocation
T12041 811-814 CD denotes p65
T12040 807-810 CC denotes and
T12039 803-806 CD denotes p50
T12038 799-802 DT denotes the
T12037 796-798 IN denotes of
T12036 785-795 NN denotes inhibition
T12035 781-784 DT denotes the
T12034 776-780 IN denotes with
T12033 764-775 VBN denotes accompanied
T12032 762-763 , denotes ,
T12031 759-762 NNP denotes IκB
T12030 756-758 IN denotes of
T12029 740-755 NN denotes phosphorylation
T12028 736-739 DT denotes the
T12027 726-735 VBD denotes prevented
T12026 724-725 NN denotes −
T12025 723-724 CD denotes /
T12024 722-723 VBD denotes −
T12023 718-722 NNP denotes CCR5
T12022 716-717 , denotes ,
T12021 708-716 NN denotes addition
T12020 705-707 IN denotes In
T12019 703-704 . denotes .
T12018 695-703 VBN denotes enhanced
T12017 690-694 VBD denotes were
T12016 685-689 NNP denotes cIAP
T12015 681-684 CC denotes and
T12014 675-680 NN denotes Bcl-2
T12013 672-674 IN denotes as
T12012 667-671 JJ denotes such
T12011 665-666 , denotes ,
T12010 660-665 NNS denotes genes
T12009 653-659 NN denotes target
T12008 647-652 NN denotes NF-κB
T12007 636-646 JJ denotes inhibitory
T12006 630-635 NN denotes death
T12005 625-629 NN denotes cell
T12004 622-624 IN denotes of
T12003 611-621 NN denotes expression
T12002 607-610 DT denotes the
T12001 603-606 CC denotes but
T12000 601-602 , denotes ,
T11999 592-601 VBN denotes inhibited
T11998 578-591 RB denotes significantly
T11997 573-577 VBD denotes were
T11996 571-572 , denotes ,
T11995 566-571 NNP denotes NF-κB
T11994 563-565 IN denotes of
T11993 554-562 NN denotes activity
T11992 546-553 JJ denotes binding
T11991 542-545 NNP denotes DNA
T11990 538-541 DT denotes the
T11989 534-537 CC denotes and
T11988 532-533 -RRB- denotes )
T11987 531-532 CD denotes 9
T11986 527-530 CC denotes and
T11985 517-526 JJ denotes caspase-3
T11984 515-516 , denotes ,
T11983 512-515 NNP denotes Bax
T11982 511-512 -LRB- denotes (
T11981 505-510 NNS denotes genes
T11980 499-504 NN denotes death
T11979 494-498 NN denotes cell
T11978 487-493 NN denotes target
T11977 481-486 JJ denotes NF-κB
T11976 478-480 IN denotes of
T11975 467-477 NN denotes expression
T11974 463-466 DT denotes the
T11973 461-462 , denotes ,
T11972 457-461 NNS denotes mice
T11971 455-456 CD denotes −
T11970 454-455 VBD denotes /
T11969 453-454 NNP denotes −
T11968 449-453 NNP denotes CCR5
T11967 445-448 DT denotes the
T11966 442-444 IN denotes of
T11965 434-441 NNS denotes tissues
T11964 428-433 NN denotes tumor
T11963 419-427 NN denotes melanoma
T11962 415-418 DT denotes the
T11961 412-414 IN denotes In
T11960 410-411 . denotes .
T11959 402-410 NN denotes immunity
T11958 391-401 JJ denotes anti-tumor
R7773 T11921 T11922 aux to,induce
R7778 T11922 T11947 advcl induce,recognized
R7781 T11923 T11924 det the,expression
R7787 T11894 T11895 nsubj NF-κB,regulates
R7788 T11895 T11895 ROOT regulates,regulates
R7789 T11924 T11922 dobj expression,induce
R7790 T11896 T11897 det the,expression
R7791 T11897 T11895 dobj expression,regulates
R7792 T11898 T11897 prep of,expression
R7793 T11899 T11900 quantmod over,200
R7794 T11925 T11924 prep of,expression
R7795 T11900 T11901 nummod 200,genes
R7796 T11901 T11898 pobj genes,of
R7797 T11902 T11903 nsubj that,control
R7798 T11926 T11928 det a,array
R7799 T11903 T11901 relcl control,genes
R7800 T11904 T11906 det the,system
R7801 T11905 T11906 amod immune,system
R7802 T11927 T11928 amod large,array
R7803 T11906 T11903 dobj system,control
R7804 T11907 T11906 punct ",",system
R7805 T11908 T11909 compound cancer,cell
R7806 T11928 T11925 pobj array,of
R7807 T11909 T11910 compound cell,growth
R7808 T11910 T11906 conj growth,system
R7809 T11911 T11910 cc and,growth
R7810 T11929 T11928 prep of,array
R7811 T11912 T11910 conj inflammation,growth
R7812 T11913 T11915 nmod [,]
R7813 T11914 T11915 nummod 39,]
R7814 T11930 T11931 amod inflammatory,mediators
R7815 T11915 T11897 appos ],expression
R7816 T11916 T11895 punct .,regulates
R7817 T11931 T11929 pobj mediators,of
R7818 T11917 T11947 prep Because,recognized
R7819 T11918 T11917 pcomp of,Because
R7820 T11919 T11920 poss its,abilities
R7821 T11920 T11917 pobj abilities,Because
R7822 T11932 T11931 cc and,mediators
R7823 T11933 T11934 poss its,roles
R7824 T11934 T11931 conj roles,mediators
R7825 T11935 T11934 prep as,roles
R7826 T11936 T11938 amod core,factors
R7827 T12018 T11999 conj enhanced,inhibited
R7828 T11937 T11938 compound transcription,factors
R7829 T12019 T12018 punct .,enhanced
R7830 T12020 T12024 prep In,−
R7831 T11938 T11935 pobj factors,as
R7832 T12021 T12020 pobj addition,In
R7833 T12022 T12024 punct ",",−
R7834 T11939 T11928 prep in,array
R7835 T12023 T12024 nsubj CCR5,−
R7836 T12024 T12024 ROOT −,−
R7837 T12025 T12026 nummod /,−
R7838 T12026 T12027 nsubj −,prevented
R7839 T12027 T12024 ccomp prevented,−
R7840 T11940 T11942 amod diverse,responses
R7841 T12028 T12029 det the,phosphorylation
R7842 T12029 T12027 dobj phosphorylation,prevented
R7843 T12030 T12029 prep of,phosphorylation
R7844 T11941 T11942 amod immune,responses
R7845 T12031 T12030 pobj IκB,of
R7846 T12032 T12029 punct ",",phosphorylation
R7847 T12033 T12027 advcl accompanied,prevented
R7848 T11942 T11939 pobj responses,in
R7849 T12034 T12033 prep with,accompanied
R7850 T12035 T12036 det the,inhibition
R7851 T12036 T12034 pobj inhibition,with
R7852 T11943 T11947 punct ",",recognized
R7853 T12037 T12036 prep of,inhibition
R7854 T12038 T12039 det the,p50
R7855 T11944 T11947 nsubjpass NF-κB,recognized
R7856 T12039 T12037 pobj p50,of
R7857 T12040 T12039 cc and,p50
R7858 T12041 T12042 nummod p65,translocation
R7859 T11945 T11947 aux has,recognized
R7860 T12042 T12039 conj translocation,p50
R7861 T12043 T12033 prep into,accompanied
R7862 T12044 T12045 det the,nucleus
R7863 T11946 T11947 auxpass been,recognized
R7864 T12045 T12043 pobj nucleus,into
R7865 T12046 T12048 punct (,2A-C
R7866 T12047 T12048 compound Figure,2A-C
R7867 T11947 T11947 ROOT recognized,recognized
R7868 T12048 T12045 appos 2A-C,nucleus
R7869 T12049 T12048 punct ),2A-C
R7870 T12050 T12024 punct .,−
R7871 T11948 T11947 prep as,recognized
R7872 T12051 T12052 amod Many,tumors
R7873 T12052 T12058 nsubj tumors,increased
R7874 T11949 T11951 det a,factor
R7875 T12053 T12052 punct ",",tumors
R7876 T12054 T12052 prep including,tumors
R7877 T12055 T12054 pobj melanoma,including
R7878 T12056 T12052 punct ",",tumors
R7879 T11950 T11951 amod major,factor
R7880 T12057 T12058 aux have,increased
R7881 T12058 T12058 ROOT increased,increased
R7882 T12059 T12058 dobj levels,increased
R7883 T11951 T11948 pobj factor,as
R7884 T12060 T12059 prep of,levels
R7885 T12061 T12062 compound NF-κB,[
R7886 T12062 T12060 pobj [,of
R7887 T12063 T12064 nummod 40,]
R7888 T12064 T12059 appos ],levels
R7889 T11952 T11951 amod responsible,factor
R7890 T12065 T12064 punct ",",]
R7891 T12066 T12067 nsubj which,is
R7892 T12067 T12064 relcl is,]
R7893 T11953 T11952 prep for,responsible
R7894 T12068 T12067 acomp likely,is
R7895 T12069 T12068 xcomp acting,likely
R7896 T12070 T12069 prep as,acting
R7897 T11954 T11956 amod cytokine-associated,development
R7898 T12071 T12073 det a,factor
R7899 T12072 T12073 compound survival,factor
R7900 T12073 T12070 pobj factor,as
R7901 T11955 T11956 compound cancer,development
R7902 T12074 T12073 prep for,factor
R7903 T12075 T12076 compound melanoma,growth
R7904 T12076 T12074 pobj growth,for
R7905 T11956 T11953 pobj development,for
R7906 T12077 T12058 punct .,increased
R7907 T12078 T12091 advmod Thus,are
R7908 T12079 T12091 punct ",",are
R7909 T11957 T11956 cc or,development
R7910 T12080 T12081 det the,inhibitions
R7911 T12081 T12091 nsubj inhibitions,are
R7912 T12082 T12081 prep of,inhibitions
R7913 T11958 T11959 amod anti-tumor,immunity
R7914 T12083 T12084 amod NF-κB,activity
R7915 T12084 T12082 pobj activity,of
R7916 T12085 T12084 cc and,activity
R7917 T11959 T11956 conj immunity,development
R7918 T12086 T12087 det the,expression
R7919 T12087 T12084 conj expression,activity
R7920 T11960 T11947 punct .,recognized
R7921 T12088 T12087 prep of,expression
R7922 T12089 T12090 compound target,genes
R7923 T12090 T12088 pobj genes,of
R7924 T11961 T11970 prep In,/
R7925 T12091 T12091 ROOT are,are
R7926 T12092 T12091 acomp critical,are
R7927 T11962 T11965 det the,tissues
R7928 T11963 T11965 compound melanoma,tissues
R7929 T12093 T12092 prep in,critical
R7930 T11964 T11965 compound tumor,tissues
R7931 T12094 T12095 det the,inhibition
R7932 T12095 T12093 pobj inhibition,in
R7933 T12096 T12095 prep of,inhibition
R7934 T11965 T11961 pobj tissues,In
R7935 T12097 T12098 compound tumor,growth
R7936 T12098 T12096 pobj growth,of
R7937 T12099 T12091 prep in,are
R7938 T12100 T12104 nummod CCR5,mice
R7939 T11966 T11965 prep of,tissues
R7940 T12101 T12104 nummod −,mice
R7941 T12102 T12104 nmod /,mice
R7942 T12103 T12104 compound −,mice
R7943 T12104 T12099 pobj mice,in
R7944 T11967 T11969 det the,−
R7945 T12105 T12091 punct .,are
R7946 T12106 T12109 mark Although,is
R7947 T12107 T12108 det the,mechanism
R7948 T11968 T11969 compound CCR5,−
R7949 T12108 T12109 nsubj mechanism,is
R7950 T12109 T12123 advcl is,is
R7951 T12110 T12111 neg not,clear
R7952 T11969 T11966 pobj −,of
R7953 T12111 T12109 acomp clear,is
R7954 T12112 T12123 prep as,is
R7955 T12113 T12112 pcomp to,as
R7956 T11970 T11999 advcl /,inhibited
R7957 T12114 T12116 advmod how,−
R7958 T11971 T11972 nummod −,mice
R7959 T11972 T11970 dobj mice,/
R7960 T11973 T11999 punct ",",inhibited
R7961 T12115 T12116 nsubj CCR5,−
R7962 T11974 T11975 det the,expression
R7963 T12116 T12123 advcl −,is
R7964 T12117 T12119 nummod /,downregulates
R7965 T11975 T11999 nsubjpass expression,inhibited
R7966 T11976 T11975 prep of,expression
R7967 T11977 T11981 amod NF-κB,genes
R7968 T12118 T12119 compound −,downregulates
R7969 T11978 T11979 compound target,cell
R7970 T12119 T12120 compound downregulates,NF-κB
R7971 T12120 T12116 dobj NF-κB,−
R7972 T12121 T12123 punct ",",is
R7973 T11979 T11980 compound cell,death
R7974 T12122 T12123 nsubj it,is
R7975 T12123 T12123 ROOT is,is
R7976 T12124 T12123 acomp noteworthy,is
R7977 T11980 T11981 compound death,genes
R7978 T12125 T12128 mark that,activated
R7979 T12126 T12128 nsubjpass NF-κB,activated
R7980 T11981 T11976 pobj genes,of
R7981 T12127 T12128 auxpass is,activated
R7982 T12128 T12123 ccomp activated,is
R7983 T12129 T12128 cc or,activated
R7984 T11982 T11999 punct (,inhibited
R7985 T12130 T12128 conj inactivated,activated
R7986 T12131 T12130 agent by,inactivated
R7987 T12132 T12133 amod many,cytokines
R7988 T12133 T12131 pobj cytokines,by
R7989 T12134 T12123 punct .,is
R7991 T11983 T11999 nsubjpass Bax,inhibited
R7994 T11984 T11983 punct ",",Bax
R7998 T11985 T11983 conj caspase-3,Bax
R8002 T11986 T11985 cc and,caspase-3
R8005 T11987 T11985 conj 9,caspase-3
R8009 T11988 T11987 punct ),9
R8012 T11989 T11985 cc and,caspase-3
R8016 T11990 T11993 det the,activity
R8020 T11991 T11993 compound DNA,activity
R8024 T11992 T11993 amod binding,activity
R8028 T11993 T11985 conj activity,caspase-3
R8031 T11994 T11993 prep of,activity
R8035 T11995 T11994 pobj NF-κB,of
R8039 T11996 T11997 punct ",",were
R8041 T11997 T11999 auxpass were,inhibited
R8045 T11998 T11999 advmod significantly,inhibited
R8049 T11999 T11999 ROOT inhibited,inhibited
R8052 T12000 T11999 punct ",",inhibited
R8056 T12001 T11999 cc but,inhibited
R8059 T12002 T12003 det the,expression
R8063 T12003 T12018 nsubjpass expression,enhanced
R8067 T12004 T12003 prep of,expression
R8071 T12005 T12006 compound cell,death
R8075 T12006 T12004 pobj death,of
R8079 T12007 T12010 amod inhibitory,genes
R8083 T12008 T12010 compound NF-κB,genes
R8086 T12009 T12010 compound target,genes
R8093 T12010 T12018 nsubjpass genes,enhanced
R8095 T12011 T12010 punct ",",genes
R8096 T12012 T12013 amod such,as
R8098 T12013 T12010 prep as,genes
R8100 T12014 T12013 pobj Bcl-2,as
R8106 T12015 T12014 cc and,Bcl-2
R8110 T12016 T12018 nsubjpass cIAP,enhanced
R8114 T12017 T12018 auxpass were,enhanced

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T11256 1254-1265 Positive_regulation denotes inactivated
T11255 1241-1250 Positive_regulation denotes activated
T11254 1232-1237 Protein denotes NF-κB
T11253 1203-1208 Protein denotes NF-κB
T11252 1181-1185 Protein denotes CCR5
T11251 1006-1017 Negative_regulation denotes inhibitions
T11250 1021-1026 Protein denotes NF-κB
T11249 899-908 Positive_regulation denotes increased
T11248 919-924 Protein denotes NF-κB
T11247 785-795 Negative_regulation denotes inhibition
T11246 785-795 Negative_regulation denotes inhibition
T11245 815-828 Localization denotes translocation
T11244 815-828 Localization denotes translocation
T11243 726-735 Negative_regulation denotes prevented
T11242 838-845 Entity denotes nucleus
T11241 785-795 Negative_regulation denotes inhibition
T11239 740-755 Phosphorylation denotes phosphorylation
T11238 811-814 Protein denotes p65
T11237 803-806 Protein denotes p50
T11236 759-762 Protein denotes IκB
T11235 695-703 Positive_regulation denotes enhanced
T11234 695-703 Positive_regulation denotes enhanced
T11233 611-621 Gene_expression denotes expression
T11232 611-621 Gene_expression denotes expression
T11231 592-601 Negative_regulation denotes inhibited
T11230 592-601 Negative_regulation denotes inhibited
T11229 592-601 Negative_regulation denotes inhibited
T11228 592-601 Negative_regulation denotes inhibited
T11227 546-553 Binding denotes binding
T11226 467-477 Gene_expression denotes expression
T11225 467-477 Gene_expression denotes expression
T11224 467-477 Gene_expression denotes expression
T11223 675-680 Protein denotes Bcl-2
T11222 647-652 Protein denotes NF-κB
T11221 566-571 Protein denotes NF-κB
T11220 517-526 Protein denotes caspase-3
T11219 512-515 Protein denotes Bax
T11218 481-510 Protein denotes NF-κB target cell death genes
T11217 304-314 Binding denotes recognized
T11216 289-294 Protein denotes NF-κB
T11215 0-5 Protein denotes NF-κB
T11240 785-795 Negative_regulation denotes inhibition
R7422 T11216 T11217 themeOf NF-κB,recognized
R7425 T11218 T11224 themeOf NF-κB target cell death genes,expression
R7427 T11219 T11225 themeOf Bax,expression
R7428 T11220 T11226 themeOf caspase-3,expression
R7429 T11221 T11227 themeOf NF-κB,binding
R7430 T11222 T11232 themeOf NF-κB,expression
R7431 T11223 T11233 themeOf Bcl-2,expression
R7432 T11224 T11228 themeOf expression,inhibited
R7433 T11225 T11229 themeOf expression,inhibited
R7434 T11226 T11230 themeOf expression,inhibited
R7435 T11232 T11234 themeOf expression,enhanced
R7436 T11233 T11235 themeOf expression,enhanced
R7437 T11236 T11239 themeOf IκB,phosphorylation
R7438 T11227 T11231 themeOf binding,inhibited
R7439 T11237 T11240 themeOf p50,inhibition
R7440 T11237 T11244 themeOf p50,translocation
R7441 T11238 T11241 themeOf p65,inhibition
R7442 T11238 T11245 themeOf p65,translocation
R7444 T11239 T11243 themeOf phosphorylation,prevented
R7446 T11242 T11244 locationOf nucleus,translocation
R7449 T11242 T11245 locationOf nucleus,translocation
R7450 T11244 T11246 themeOf translocation,inhibition
R7452 T11245 T11247 themeOf translocation,inhibition
R7453 T11248 T11249 themeOf NF-κB,increased
R7455 T11250 T11251 themeOf NF-κB,inhibitions
R7457 T11254 T11255 themeOf NF-κB,activated
R7458 T11254 T11256 themeOf NF-κB,inactivated